Skip to main content
. 2012 Jul 11;2012(7):CD002991. doi: 10.1002/14651858.CD002991.pub3

2.9. Analysis.

2.9

Comparison 2 ICS versus placebo, parallel‐group studies, greater than 2 months to 6 months (all doses), Outcome 9 No. of patients with at least one exacerbation.